Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00377715
Status:
COMPLETED
Last Update Posted:
2015-11-11
First Post:
2006-09-15
Brief Title:
Double-blind Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimers Disease
Sponsor:
Medivation Inc
Organization:
Medivation Inc
Study Overview
Official Title:
Phase 2 Double-Blind Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and potential benefit of Dimebon as compared to placebo in patients with mild to moderate Alzheimers Disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None